BioSpace News Archive

Lancet Market: Home Care Segment to Witness Strong Growth

Lancet is a small finger-pricking device used to make punctures, such as a fingerstick, to obtain small blood specimens. Lancets are mostly disposable.

December 14, 2021
·
6 min read
Idiopathic Pulmonary Fibrosis Treatment Market Detailed Analysis and Forecast to 2028

The idiopathic pulmonary fibrosis treatment market has been experiencing tremendous growth opportunities across the world.

December 14, 2021
·
6 min read
Aquaculture Vaccines Market Report | Know the Post-Pandemic Scenario of the Industry

The growing awareness about the importance and the benefits of using aquaculture vaccines to enhance the overall quality of the fish is expected to bring considerable growth opportunities for the aquaculture vaccines market during the forecast period of 2020-2030.

December 14, 2021
·
5 min read
Business

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol

Guerbet and Bracco Imaging announced they have signed a global collaboration for Gadopiclenol, a next-generation magnetic resonance imaging contrast agent.

December 14, 2021
·
7 min read
Drug Development

GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 2-Year Follow-Up of REFLECT Phase III Trial

GenSight Biologics reported topline efficacy and safety results at 2 years post-treatment administration in the REFLECT Phase III clinical trial with LUMEVOQ®.

December 14, 2021
·
11 min read
Business

NEOGEN to Combine 3M’s Food Safety Business With its Existing Operations, Creating a Global Industry Leader

NEOGEN Corporation announced today that they have entered into a definitive agreement pursuant to which 3M will separate its Food Safety business and simultaneously combine it with NEOGEN in a transaction that is intended to be tax-efficient to 3M and its shareholders for U.S. federal income tax purposes.

December 14, 2021
·
16 min read
Drug Development

Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death

Pfizer Inc. today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR trial of its novel COVID-19 oral antiviral candidate PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets).

December 14, 2021
·
16 min read
Drug Development

TYME Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections

TYME-19 demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells, a model frequently used for drug screening for antiviral efficacy.

December 14, 2021
·
9 min read
Drug Development

Talaris Therapeutics Presents High-Resolution Analysis of HLA Mismatching in Phase 2 Trial in Living Donor Kidney Transplant Analysis

Talaris Therapeutics, Inc. today presented a new analysis of HLA mismatching between donors and recipients participating in the Company’s Phase 2 trial in living donor kidney transplant (LDKT).

December 14, 2021
·
4 min read
Hysteroscopy Systems Market to Exhibit 5% CAGR as Prevalence of Uterine Fibroids Increases

Fact.MR – A Market Research and Competitive Intelligence Provider: The global hysteroscopy systems market is expected to grow at a 5% CAGR during the forecast period between 2019 to 2029, predicts Fact.MR.

December 14, 2021
·
7 min read